Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

727
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
727
Hypertension I: Introduction01:28

Hypertension I: Introduction

957
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
957
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

1.0K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.0K
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

490
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
490
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

4.5K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.5K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

669
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
669

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacotherapy for mild hypertension.

The Cochrane database of systematic reviews·2026
Same author

CT-derived optic nerve sheath diameter as a noninvasive proxy for intracranial pressure in traumatic brain injury patients undergoing preoperative ICP monitoring: An institutional analysis and scoping review.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026
Same author

Pharmacotherapy for hypertension in adults 60 years or older.

The Cochrane database of systematic reviews·2025
Same author

Pharmacotherapy for mild hypertension.

The Cochrane database of systematic reviews·2025
Same author

Does Back Pain Improve Following Lumbar Decompression Alone?

Clinical spine surgery·2025
Same author

Multiple Long-Term Conditions, Co-Long-Term Conditions and Polyvascular Disease: Considerations for Evidence Synthesis and Meta-Analyses.

Cochrane evidence synthesis and methods..·2025

Related Experiment Video

Updated: Feb 11, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.2K

First-line drugs for hypertension.

James M Wright1, Vijaya M Musini, Rupam Gill

  • 1Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, 2176 Health Sciences Mall, Vancouver, BC, Canada, V6T 1Z3.

The Cochrane Database of Systematic Reviews
|April 19, 2018
PubMed
Summary

First-line low-dose thiazides effectively reduce mortality and morbidity in patients with moderate to severe hypertension. Other drug classes like ACE inhibitors and calcium channel blockers show potential but require further high-quality evidence for confirmation.

More Related Videos

Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension
09:40

Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension

Published on: April 11, 2016

21.8K
Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis
07:11

Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis

Published on: May 23, 2025

961

Related Experiment Videos

Last Updated: Feb 11, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.2K
Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension
09:40

Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension

Published on: April 11, 2016

21.8K
Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis
07:11

Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis

Published on: May 23, 2025

961

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Trials

Background:

  • Elevated blood pressure is a critical clinical concern.
  • Determining the optimal first-line antihypertensive drug class is essential for patient outcomes.

Purpose of the Study:

  • To compare the mortality and morbidity effects of various first-line antihypertensive drug classes.
  • To assess blood pressure reduction and adverse event rates for different drug classes.

Main Methods:

  • Systematic review and meta-analysis of randomized controlled trials (RCTs).
  • Included trials compared thiazides, beta-blockers, calcium channel blockers, and ACE inhibitors against placebo.
  • Outcomes included mortality, stroke, coronary heart disease, cardiovascular events, and adverse drug withdrawals.

Main Results:

  • Low-dose thiazides demonstrated high-quality evidence for reducing mortality, stroke, coronary heart disease, and total cardiovascular events.
  • ACE inhibitors and calcium channel blockers showed potential benefits, supported by lower-quality evidence.
  • High-dose thiazides and beta-blockers were found to be less effective than low-dose thiazides, with increased adverse event withdrawals.

Conclusions:

  • First-line low-dose thiazides are effective in reducing morbidity and mortality in moderate to severe primary hypertension.
  • ACE inhibitors and calcium channel blockers may offer similar benefits, but require more robust evidence.
  • High-dose thiazides and beta-blockers are less effective as first-line treatments compared to low-dose thiazides.